On Sept. 26 at noon Central, the Women Physicians Section hosts a special Women in Medicine Month webinar. Register today.

A brolucizumab trial shows improvements in visual acuity noninferior to that of aflibercept, with risks of intraocular inflammation for some.

Isolated paracentral acute middle maculopathy (iPAMM) is tied to short-term risk of a life-threatening cardiovascular event (CVE) in older adults, research in the American Journal of Ophthalmology ...

Among patients with retinal vein occlusion (RVO), microaneurysms are associated with greater nonperfusion areas and the presence of collateral, ghost, and tortuous vessels, accord ...